Peptide research updates, regulatory changes, and industry developments.
April 10, 2026
HHS Secretary Robert F. Kennedy Jr. announced that 14 of 19 previously restricted peptides will be moved off the FDA’s “do not compound” list — the largest regulatory reversal in U.S. peptide history.